Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02317367 · ClinicalTrials.gov registry record

Self-Affirmation: Construct Validity

A clinical trial, sponsored by National Cancer Institute (NCI).

Completed
Registry status
3,112
Enrollment target

NCT02317367: Completed study, sponsored by National Cancer Institute (NCI).

NCT02317367 is a clinical trial that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 3,112 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT02317367 has completed, sponsored by National Cancer Institute (NCI).

COMPLETED
Registry status
3,112 participants
Enrollment target

Study Summary

Background: \- People respond differently when asked about their values. They also respond differently when they learn about how their actions affect their lives and health. Researchers want to learn more about these differences. This can help them improve public health messages. Objective: \- To see how people respond differently to questions about their values and to information about alcohol and breast cancer. Eligibility: Study 1 \- Women age 18 and older. Study 2 \& Study 3 -Women and men aged 18 and older to take part in these studies if they do not meet the US recommendations of eating 5 or more servings of fruits and vegetables per week. Design: * This study will take place online. * Participants will be randomly assigned to a group that will complete a certain task. * Researchers will ask participants to complete 2 small studies: * Values Study. Some participants may write briefly about a value that is important to them or to someone they are close to. Some participants will complete a short questionnaire instead of the writing exercise. * Study 1: Alcohol and Breast Cancer Study. Participants will read a health message. This will be about the link between alcohol use and increased breast cancer risk. Participants will then answer questions about what they read and their beliefs about alcohol and breast cancer. -Study 2: Fruit and Vegetable Consumption and Health Study. Participants will read a health message about the fruit and vegetable consumption. Participants will then answer questions about what they read and their beliefs about fruit and vegetable consumption. -Study 3: Fruit and Vegetable Consumption and Health Study. Participants will read a health message about the fruit and vegetable consumption. Participants will then answer questions about what they read and their beliefs about fruit and vegetable consumption. Complete a follow-up survey that will be emailed to you through the mTurk system a week after you complete the main study

Primary Outcome

Intentions to reduce alcohol consumption

Trial Details

FieldValue
Enrollment Target 3,112 participants
Start Date 2016-07-31
Est. Completion 2021-08-27
National Cancer Institute (NCI)

3,257 total trials

What the finished NCT02317367 record still lists

NCT02317367 is an observational study that tracks outcomes without assigning an intervention. Its 3,112 participants enrollment target places it among the larger protocols in the corpus.

The record links to 0 conditions, and to 0 interventions.

NCT02317367 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02317367 about?

NCT02317367 is a clinical study titled "Self-Affirmation: Construct Validity". Background: \- People respond differently when asked about their values. They also respond differently when they learn about how their actions affect their lives and health. Researchers want to learn more about these differences. This can help them improve public health messages. Objective: \- To...

What is the current status of trial NCT02317367?

This trial is currently completed. The enrollment target is 3,112 participants. The study started on 2016-07-31. Estimated completion is 2021-08-27.

Who is sponsoring clinical trial NCT02317367?

This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05051722 · 3,110 participants

    Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer

  • NCT04722822 · 3,100 participants · NA

    The HPV 9-10 Trial: Early Initiation of HPV Vaccination

  • NCT05534243 · 3,090 participants · NA

    The ED-AWARENESS-2 Trial

  • NCT06667700 · 3,082 participants · Phase 3

    A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02317367, the US trial registry maintained by the National Library of Medicine. NCT02317367 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.